Brown Melinda 4
4 · PRECISION BIOSCIENCES INC · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Precision Biosciences (DTIL) Director Melinda Brown Receives Award
What Happened
Melinda Brown, a director of Precision Biosciences, received an award of 20,979 restricted stock units (RSUs) on June 3, 2026. The RSUs were granted at $0.00 per unit (transaction code A), so there was no cash purchase or sale and no immediate change in share ownership value until vesting.
Key Details
- Transaction date: 2026-06-03; Form 4 filed: 2026-06-05 (timely filing).
- Award: 20,979 RSUs granted at $0.00 per RSU (derivative award).
- Shares owned after transaction: not specified in the provided excerpt.
- Footnotes: (1) Each RSU represents a contingent right to one share of common stock. (2) RSUs vest on the earlier of June 3, 2027 or the day before the issuer's next annual meeting, subject to continued service.
- Transaction code: A = Award/Grant.
Context
RSUs are compensation that convert into actual shares only upon vesting; they do not represent immediate market purchases or sales and often reflect standard director or executive compensation. This grant does not by itself indicate buying or selling sentiment, as shares will only be issued (and potentially taxable) if and when the RSUs vest.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-06-03+20,979→ 20,979 total→ Common Stock (20,979 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.